Johnson & Johnson (NYSE:JNJ) price on Friday, May 10, fall -0.30% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $149.40.
A look at the stock’s price movement, the level at last check in today’s session was $149.85. The PE ratio in trailing twelve months stood at 21.52. Turning to its 52-week performance, $175.97 and $143.13 were the 52-week high and 52-week low respectively. Overall, JNJ moved 0.41% over the past month.
Johnson & Johnson’s market cap currently stands at around $359.56 billion. The company has a Forward Dividend ratio of 4.76, with its dividend yield at 3.19%. As such, investors might be keen on an upside in the stock’s price ahead of the scheduled earnings report.
Analysts have a consensus estimate of 20.73B for the company’s revenue for the quarter, with a low and high estimate of 20.38B and 21.04B respectively. The average forecast suggests down to a -18.80% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 82.21B, representing a -3.50% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that JNJ is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
The technical evaluation for the stock shows the PEG ratio is 4.11, with JNJ’s current price about 1.08% and -2.53% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 48.65, while 7-day volatility ratio is 1.04% and 1.56% in the 30-day chart. Further, Johnson & Johnson (JNJ) has a beta value of 0.53, and an average true range (ATR) of 2.21.
If we refocus on Johnson & Johnson (NYSE:JNJ), historical trading data shows that trading volumes averaged 7.60 million over the past 3 months. The company’s latest data on shares outstanding shows there are 2.41 billion shares.
The 0.16% of Johnson & Johnson’s shares are in the hands of company insiders while institutional holders own 71.31% of the company’s shares. Current price change has pushed the stock -4.68% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the JNJ stock continues to rise going into the next quarter.
